Calcium/calmodulin‐dependent protein kinase kinase β is neuroprotective in stroke in aged mice
Authors:
- 17 August 2016
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 44 (4) , 2139-2146
Abstract
Stroke is a devastating neurological disease and the leading cause of long‐term disability, particularly in the elderly. Calcium/calmodulin‐dependent protein kinase kinase β (CaMKK β) is a major kinase activated by elevated levels of intracellular calcium. Our previous findings in young mice have suggested that CaMKK β is neuroprotective as KO mice had worse stroke outcomes. Because age is an important determinant of stroke outcome, we evaluated the functional role of CaMKK β in stroke in aged mice. We used middle cerebral artery occlusion to induce stroke in aged wild‐type (WT) and CaMKK β KO male mice. Lentiviral vectors carrying CaMKK β (LV‐CaMKK β) were used to overexpress CaMKK β in the mouse brain. Baseline levels of CaMKK β in the aged brain were significantly lower than those in young mice. LV‐CaMKK β treatment reduced infarcts and neurological deficits assessed 3 days after stroke. In chronic survival experiments, CaMKK β KO mice showed increased tissue loss in the ipsilateral hemisphere 3 weeks after stroke. In addition, KO mice showed poorer functional recovery during the 3‐week survival period, as measured by the rotarod test, corner test, locomotor activity assay, and novel object recognition test, compared with WT controls. The loss of blood–brain barrier proteins, inactivation of survival gene expression such as B‐cell lymphoma 2 (Bcl‐2) and an increase in inflammatory cytokines in the serum were observed after stroke with CaMKK β inhibition. We demonstrate that CaMKK β is neuroprotective in stroke in aged mice. Therefore, our data suggest that CaMKK β may be a potential target for reducing long‐term disability after stroke.Keywords
Funding Information
- National Institutes of Health (R01 NS078446, R21 NS079137)
This publication has 18 references indexed in Scilit:
- Inhibition of mitogen-activated protein kinase phosphatase-1 (MKP-1) increases experimental stroke injuryExperimental Neurology, 2014
- Role of Inflammation and Its Mediators in Acute Ischemic StrokeJournal of Cardiovascular Translational Research, 2013
- Perlecan Domain V Is Neuroprotective and Affords Functional Improvement in a Photothrombotic Stroke Model in Young and Aged MiceTranslational Stroke Research, 2013
- Simvastatin Attenuates Stroke-induced Splenic Atrophy and Lung Susceptibility to Spontaneous Bacterial Infection in MiceStroke, 2013
- Beta-asarone attenuates ischemia–reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1European Journal of Pharmacology, 2012
- Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasiaNature Medicine, 2012
- A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem CellsTranslational Stroke Research, 2011
- Age-related changes in AMP-activated protein kinase after strokeAGE, 2011
- Changes in Experimental Stroke Outcome across the Life SpanJournal of Cerebral Blood Flow & Metabolism, 2009
- Upregulation of Calcium/Calmodulin-Dependent Protein Kinase IV Improves Memory Formation and Rescues Memory Loss with AgingJournal of Neuroscience, 2008